L707-2026 Screening compound: 1-[2-(azepan-1-yl)-2-oxoethyl]-7-(azepane-1-sulfonyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

L707-2026 Screening compound: 1-[2-(azepan-1-yl)-2-oxoethyl]-7-(azepane-1-sulfonyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one
L707-2026 Screening compound: 1-[2-(azepan-1-yl)-2-oxoethyl]-7-(azepane-1-sulfonyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L707-2026
1-[2-(azepan-1-yl)-2-oxoethyl]-7-(azepane-1-sulfonyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L707-2026

Molecular Formula

C24H35N3O4S (C24 H35 N3 O4 S)

Compound Name

1-[2-(azepan-1-yl)-2-oxoethyl]-7-(azepane-1-sulfonyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

IUPAC name

1-[2-(azepan-1-yl)-2-oxoethyl]-7-(azepane-1-sulfonyl)-2345-tetrahydro-1H-1-benzazepin-2-one

SMILES

O=C(CN(c(cc1)c(CCC2)cc1S(N1CCCCCC1)(=O)=O)C2=O)N1CCCCCC1

InChI

InChI=1S/C24H35N3O4S/c28-23-11-9-10-20-18-21(32(30,31)26-16-7-3-4-8-17-26)12-13-22(20)27(23)19-24(29)25-14-5-1-2-6-15-25/h12-13,18H,1-11,14-17,19H2

InChI Key

WUZKVKFORXFIDU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27472111

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.63

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.581

Distribution Coefficient, logD

3.581

Water Solubility, LogSw

-3.90

Polar Surface Area

64.715

Acid Dissociation Constant (pKa)

22.17

Base Dissociation Constant (pKb)

5.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

66.70

L707-2026 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with L707-2026 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L707-2026?
Check Price and Availability of L707-2026, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L707-2026 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L707-2026
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L707-2026
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L707-2026 available by request